Streetbeat News

COUR

Coursera, Inc.

https://www.coursera.org

Industry

Education & Training Services

Coursera, Inc. operates an online educational content platform that connects learners, educators, organizations, and institutions. It offers online courses that include data science, business, computer science, information technology, health, social sciences, logic, project management, and digital marketing services; campus student plans; degree courses; and certification education. Coursera, Inc. was formerly known as Dkandu, Inc. and changed its name to Coursera, Inc. in April 2012. The company was incorporated in 2011 and is headquartered in Mountain View, California.

Open

6.90

Mkt cap

1.1B

Volume

1.1M

High

7.00

P/E Ratio

-13.67

52-wk high

14.64

Low

6.73

Div yield

N/A

52-wk low

6.29

Coursera (NYSE:COUR) has been analyzed by 8 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $15.25, a decrease from the previous $15.79. Analysts have varied ratings, with some maintaining or raising their targets, while others lower them. Coursera's financials show a positive revenue trend but challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 12:00 pm

Telsey Advisory Group has reiterated its 'Outperform' rating for Coursera, maintaining a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:41 am

Coursera (NYSE:COUR) has been analyzed by 9 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target is $14.89, with a high of $22.00 and a low of $9.00. Analysts have decreased the average price target by 4.31%. Coursera's financials show a 10.82% revenue growth, but challenges in ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 1:00 pm

Coursera shares rose after B of A Securities initiated coverage with a Buy rating and set an $11 price target.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:37 pm

B of A Securities has initiated coverage on Coursera with a Buy rating and set a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 10:33 am

Moderna and Coursera have announced a partnership to launch a three-module course on mRNA medicines, designed by experts at Moderna. The course aims to provide a comprehensive understanding of mRNA medicines.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:14 am

This week in investing, key highlights include Coursera's strong earnings and AI course enrollment, Las Vegas Sands' misunderstood earnings, and the continued decline of the Magnificent 7 tech stocks. Coursera's stock surged 45% due to better-than-expected earnings and AI course growth. Las Vegas Sands faced a temporary decline due to room renovations but showed strong performance in Macau and Singapore. Alphabet and Tesla reported disappointing earnings, contributing to the tech sector's decline. The GDP and PCE reports suggest continued inflation, casting doubt on the likelihood of a September rate cut.

Portfolio Pulse from Gary Brode

July 31, 2024 | 3:18 pm

Bank of Marin Bancorp (NASDAQ:BMRC) shares fell sharply after reporting worse-than-expected quarterly earnings. Other notable stock movements include 2U, Inc. (NASDAQ:TWOU) climbing 128% and Cognition Therapeutics, Inc. (NASDAQ:CGTX) falling 34%.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 5:19 pm

Coursera, Inc. (NYSE:COUR) shares surged after reporting better-than-expected Q2 earnings and sales. The company also surpassed 2 million enrollments in its generative AI catalog and launched new Professional Certificates with industry leaders like Google Cloud, IBM, Meta Platforms, and Microsoft. Multiple analysts reiterated positive ratings, while Goldman Sachs maintained a Sell rating but lowered its price target.

Portfolio Pulse from Vaishali Prayag

July 26, 2024 | 7:27 pm

U.S. stocks traded higher with the S&P 500 gaining over 1%. 3M Company shares surged 21% after strong Q2 results and raised FY24 EPS outlook. Windtree Therapeutics, BurgerFi International, and Coursera saw significant gains, while NovaBay Pharmaceuticals, DexCom, and Nature’s Miracle Holding experienced sharp declines.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 6:33 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.